The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Mortality and Cost Associated With Cardiovascular Implantable Electronic Device Infections
Abstract
BACKGROUND: Cardiovascular implantable electronic device (CIED) therapy can reduce morbidity and mortality, but this benefit can be diminished by CIED infection. Currently, there are limited published data on the mortality and cost associated with CIED infection. METHODS: We analyzed the risk-adjusted total and incremental admission mortality, long-term mortality, admission length of stay (LOS), and admission cost associated with infection in a retrospective cohort of 200 219 Medicare fee-for-service patients admitted for CIED generator implantation, replacement, or revision between January 1, 2007, and December 31, 2007. RESULTS: There were a total of 5817 admissions with infection. Infection was associated with significant increases in adjusted admission mortality (rate ratios, 4.8-7.7; standardized rates, 4.6%-11.3%) and long-term mortality (rate ratios, 1.6-2.1; standardized rates, 26.5%-35.1%), depending on CIED type. Importantly, approximately half of the incremental long-term mortality occurred after discharge. The adjusted LOS was significantly longer with infection (length of stay mean ratios, 2.5-4.0; standardized length of stay, 15.5-24.3 days), depending on CIED type. The standardized adjusted incremental and total admission costs with infection were $14 360 to $16 498 and $28 676 to $53 349, respectively, depending on CIED type. The largest incremental cost with infection was intensive care, which accounted for more than 40% of the difference. Adjusted long-term mortality rate and cost ratios with infection were significantly greater for pacemakers than for implantable cardioverter/defibrillators or cardiac resynchronization therapy/defibrillator devices. CONCLUSIONS: Infection associated with CIED procedures resulted in substantial incremental admission mortality and long-term mortality that varied with the CIED type and occurred, in part, after discharge. Almost half of the incremental admission cost was for intensive care.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Comorbidity measures for use with administrative data.
Elixhauser, A., Steiner, C., Harris, D. R., & Coffey, R. M. (1998) · Medical Care · doi:10.1097/00005650-199801000-00004 · Cited by 9,921
2005 WRITING COMMITTEE MEMBERS, Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.192065 · Cited by 3,720
ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities
Epstein, A. E., DiMarco, J. P., Ellenbogen, K. A., Estes, N. A. M., Freedman, R. A., Gettes, L. S., Gillinov, A. M., Gregoratos, G., Hammill, S. C., Hayes, D. L., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.02.032 · Cited by 2,546
(2007) · Negative Binomial Regression · doi:10.1017/cbo9780511811852.007 · Cited by 1,981
Collett, D. (1991) · Springer eBooks · doi:10.1007/978-1-4899-4475-7 · Cited by 1,936
Baddour, L. M., Epstein, A. E., Erickson, C. C., Knight, B. P., Levison, M. E., Lockhart, P. B., Masoudi, F. A., Okum, E. J., Wilson, W. R., Beerman, L. B., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.192665 · Cited by 1,030
Management and Outcome of Permanent Pacemaker and Implantable Cardioverter-Defibrillator Infections
Sohail, M. R., Uslan, D. Z., Khan, A. H., Friedman, P. A., Hayes, D. L., Wilson, W. R., Steckelberg, J. M., Stoner, S., & Baddour, L. M. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.01.072 · Cited by 751
Self-citationSouthern, D. A., Quan, H., & Ghali, W. A. (2004) · Medical Care · doi:10.1097/01.mlr.0000118861.56848.ee · Cited by 573
Cost-Effectiveness of Implantable Cardioverter–Defibrillators
Sanders, G. D., Hlatky, M. A., & Owens, D. K. (2005) · New England Journal of Medicine · doi:10.1056/nejmsa051989 · Cited by 547
Increasing rates of cardiac device infections among medicare beneficiaries: 1990–1999
Cabell, C. H., Heidenreich, P. A., Chu, V. H., Moore, C. M., Stryjewski, M. E., Corey, G. R., & Fowler, V. G. (2004) · American Heart Journal · doi:10.1016/j.ahj.2003.06.005 · Cited by 397
VOIGT, A., SHALABY, A., & SABA, S. (2010) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2009.02569.x · Cited by 396
Rising Rates of Cardiac Rhythm Management Device Infections in the United States: 1996 through 2003
Voigt, A., Shalaby, A., & Saba, S. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.05.016 · Cited by 379
Li, B., Evans, D., Faris, P., Dean, S., & Quan, H. (2008) · BMC Health Services Research · doi:10.1186/1472-6963-8-12 · Cited by 342
Reynolds, M. R., Cohen, D. J., Kugelmass, A. D., Brown, P. P., Becker, E. R., Culler, S. D., & Simon, A. W. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.02.049 · Cited by 291
Cardiac implantable electronic device infections: Presentation, management, and patient outcomes
Tarakji, K. G., Chan, E. J., Cantillon, D. J., Doonan, A. L., Hu, T., Schmitt, S., Fraser, T. G., Kim, A., Gordon, S. M., & Wilkoff, B. L. (2010) · Heart Rhythm · doi:10.1016/j.hrthm.2010.05.016 · Cited by 286
Cardiac Device Implantation in the United States from 1997 through 2004: A Population-based Analysis
Zhan, C., Baine, W. B., Sedrakyan, A., & Steiner, C. (2008) · Journal of General Internal Medicine · doi:10.1007/s11606-007-0392-0 · Cited by 266
Mark, D. B., Nelson, C. L., Anstrom, K. J., Al-Khatib, S. M., Tsiatis, A. A., Cowper, P. A., Clapp-Channing, N. E., Davidson-Ray, L., Poole, J. E., Johnson, G., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.581884 · Cited by 265
The Cost Effectiveness of Implantable Cardioverter-Defibrillators
Zwanziger, J., Hall, W. J., Dick, A. W., Zhao, H., Mushlin, A. I., Hahn, R. M., Wang, H., Andrews, M. L., Mooney, C., Wang, H., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.03.032 · Cited by 221
Risk Factors for Mortality in Patients With Cardiac Device-Related Infection
Baman, T. S., Gupta, S. K., Valle, J. A., & Yamada, E. (2009) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.108.816868 · Cited by 139
Al‐Khatib, S. M., Greiner, M. A., Peterson, E. D., Hernandez, A. F., Schulman, K. A., & Curtis, L. H. (2008) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.108.777888 · Cited by 116
Ferguson, T. B., Ferguson, C., Crites, K., et al. (1996) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(96)70334-3 · Cited by 79
Cited by
2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy
Glikson, M., Nielsen, J. C., Kronborg, M. B., Michowitz, Y., Auricchio, A., Barbash, I. M., Barrabés, J. A., Boriani, G., Braunschweig, F., Brignole, M., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab364 · Cited by 2,019
2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy
Glikson, M., Nielsen, J. C., Kronborg, M. B., Michowitz, Y., Auricchio, A., Barbash, I. M., Barrabés, J. A., Boriani, G., Braunschweig, F., Brignole, M., et al. (2022) · EP Europace · doi:10.1093/europace/euab232 · Cited by 914
Challenges in Infective Endocarditis
Cahill, T. J., Baddour, L. M., Habib, G., Hoen, B., Salaun, E., Pettersson, G. B., Schäfers, H. J., & Prendergast, B. D. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.10.066 · Cited by 715
Hong, Y. J., Jeong, H., Cho, K. W., Lu, N., & Kim, D. (2019) · Advanced Functional Materials · doi:10.1002/adfm.201808247 · Cited by 559
Polyzos, K. A., Konstantelias, A. A., & Falagas, M. E. (2015) · EP Europace · doi:10.1093/europace/euv053 · Cited by 493
Metadata
- Authors
- Sohail, M. R.
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2011-11-14
- Volume
- 171
- Issue
- 20
- Pages
- 1821
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W2115054722
- Cited by
- 350
- References
- 22
- FWCI
- 10.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.